Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First oral LH receptor agonist induces ovulation in healthy women

March 15, 2011

Phase III DEFEND-1 trial in type 1 diabetes does not meet primary endpoint

March 14, 2011

Collaboration established for research into beta-cell regeneration in diabetes

March 14, 2011

FDA removes clinical hold on AT-2220 for Pompe's disease

March 10, 2011

FDA accepts for review dapagliflozin NDA for type 2 diabetes

March 9, 2011

Endo Pharma launches Fortesta testosterone gel in U.S.

March 8, 2011

DURATION-6 trial of diabetes therapy Bydureon misses primary endpoint

March 4, 2011

Enrollment complete in pivotal Breeze 3 trial of Serada for menopausal hot flashes

March 3, 2011

New inverse agonist of glycoprotein hormone TSH receptor with potential to treat Graves' disease

March 3, 2011

Novel inhibitors of 11-beta-HSD1 presented

March 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.